Problems with Conventional Magnetic Resonance Imaging and New Strategies to Improve the Utility of MRI in Future Clinical Trials
Reference140 articles.
1. Nesbit GM, Forbes GS, Scheithauer BW, et al. (1991) Multiple sclerosis: Histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology 180: 467–474
2. Paty DW, Li DKB, the UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group. Neurology 43: 662–667
3. Miki Y, Grossman RI, Udupa JK, et al. (1998) Longitudinal analysis of T2-lesion volume in relapsing-remitting multiple sclerosis (submitted)
4. Thompson AJ, Kermode AG, MacManus DG, et al. (1990) Patterns of disease activity in multiple sclerosis: Clinical and magnetic resonance imaging study. BMJ 300: 631–634
5. Thompson AJ, Kermode AG, Wicks D, et al. (1991) Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 29: 53–62